Literature DB >> 26781584

S100A4 and P53 in myocardial collagen fibers of hypertrophic cardiomyopathy : Expression and clinical significance.

X Qi1, J Han2, P Zhao3, X Dong4, S Gong1.   

Abstract

OBJECTIVE: The purpose of this work is to investigate the expression of S100A4 and P53 and their correlation with myocardial collagen fibers in hypertrophic cardiomyopathy (HCM). PATIENTS AND METHODS: Myocardial tissue obtained from 10 patients undergoing HCM surgery (HCM group) was compared to myocardial tissue obtained from 10 traffic accident deaths (healthy control group). Collagen volume fractions were visualized and compared using sirius red F3B(SR) staining. Immunohistochemistry S-P and in situ hybridization techniques were used to test the different expressions of S100A4, P53 proteins, and their mRNA. Imaging and statistical methods were used for quantitative analysis.
RESULTS: The collagen volume fraction in the HCM group was significantly higher than that in the control group. The integral optical density values of S100A4 and P53 in cardiomyocytes of the HCM group were also significantly higher than in the control group.
CONCLUSION: The increased content of collagen fibers and overexpression of S100A4 and P53 may play an important role in myocardial fibrosis of HCM, and they can be used in future HCM research. Blockade of S100A4 may have therapeutic potential in HCM by attenuating cardiac fibrosis.

Entities:  

Keywords:  Arrhythmia, cardiac; Biomarkers; Cardiac hypertrophy; Fibrosis; Sudden cardiac death

Mesh:

Substances:

Year:  2016        PMID: 26781584     DOI: 10.1007/s00059-015-4397-x

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  13 in total

1.  Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction.

Authors:  M Grigorian; S Andresen; E Tulchinsky; M Kriajevska; C Carlberg; C Kruse; M Cohn; N Ambartsumian; A Christensen; G Selivanova; E Lukanidin
Journal:  J Biol Chem       Date:  2001-03-05       Impact factor: 5.157

2.  Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.

Authors:  Maria Rosario Fernandez-Fernandez; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

3.  Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy.

Authors:  D Cesselli; I Jakoniuk; L Barlucchi; A P Beltrami; T H Hintze; B Nadal-Ginard; J Kajstura; A Leri; P Anversa
Journal:  Circ Res       Date:  2001-08-03       Impact factor: 17.367

Review 4.  p53 in health and disease.

Authors:  Karen H Vousden; David P Lane
Journal:  Nat Rev Mol Cell Biol       Date:  2007-04       Impact factor: 94.444

5.  Increased p53 protein expression in human failing myocardium.

Authors:  H Song; J V Conte; A H Foster; J S McLaughlin; C Wei
Journal:  J Heart Lung Transplant       Date:  1999-08       Impact factor: 10.247

Review 6.  S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature).

Authors:  Ingo Marenholz; Claus W Heizmann; Günter Fritz
Journal:  Biochem Biophys Res Commun       Date:  2004-10-01       Impact factor: 3.575

7.  Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition.

Authors:  Michael Zeisberg; Changqing Yang; Margot Martino; Michael B Duncan; Florian Rieder; Harikrishna Tanjore; Raghu Kalluri
Journal:  J Biol Chem       Date:  2007-06-11       Impact factor: 5.157

8.  S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes.

Authors:  Mikael Schneider; Sawa Kostin; Claes C Strøm; Mark Aplin; Stig Lyngbaek; Juliane Theilade; Mariam Grigorian; Claus B Andersen; Eugene Lukanidin; Jakob Lerche Hansen; Søren P Sheikh
Journal:  Cardiovasc Res       Date:  2007-04-06       Impact factor: 10.787

9.  Metastasis-inducing S100A4 protein is associated with the disease activity of rheumatoid arthritis.

Authors:  Lucie Oslejsková; Mariam Grigorian; Hana Hulejová; Jirí Vencovsky; Karel Pavelka; Jörg Klingelhöfer; Steffen Gay; Michel Neidhart; Hana Brabcová; David Suchy; Ladislav Senolt
Journal:  Rheumatology (Oxford)       Date:  2009-10-14       Impact factor: 7.580

Review 10.  S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?

Authors:  Mikael Schneider; Jakob L Hansen; Søren P Sheikh
Journal:  J Mol Med (Berl)       Date:  2008-03-06       Impact factor: 4.599

View more
  3 in total

Review 1.  Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype.

Authors:  Mayra de A Marques; Guilherme A P de Oliveira
Journal:  Front Physiol       Date:  2016-09-23       Impact factor: 4.566

2.  S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart Tissue.

Authors:  Simon Braumann; Tilo Thottakara; Sabrina Stücker; Silke Reischmann-Düsener; Elisabeth Krämer; Julia Groß; Marc N Hirt; Shirin Doroudgar; Lucie Carrier; Felix W Friedrich
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

3.  The Roles of S100A4 and the EGF/EGFR Signaling Axis in Pulmonary Hypertension with Right Ventricular Hypertrophy.

Authors:  Maria Laggner; Philipp Hacker; Felicitas Oberndorfer; Jonas Bauer; Thomas Raunegger; Christian Gerges; Tamás Szerafin; Jürgen Thanner; Irene Lang; Nika Skoro-Sajer; Hendrik Jan Ankersmit; Bernhard Moser
Journal:  Biology (Basel)       Date:  2022-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.